A novel and improved mouse system for studying macrophage specific gene deletion
A novel and improved mouse system for studying macrophage specific gene deletion
批准号:
8038759
负责人:
Harris R Perlman
金额:
$22.88万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-12-15 至 2012-11-30
关键词:
AblationAdultAffectAllelesAnimalsAutomobile DrivingBiologicalBiological AssayBiologyBone MarrowBreedingCellsCommunicable DiseasesCommunitiesDevelopmentDisadvantagedDiseaseEngineeringEnhancersEnterobacteria phage P1 Cre recombinaseEventFlow CytometryFluorescenceGene DeletionGenesGenetic RecombinationGoalsHistocompatibility TestingHomeostasisHumanITGAM geneImmuneImmune responseImmunityInfectionInflammationInflammatoryInflammatory ResponseInternal Ribosome Entry SiteKnock-in MouseKnockout MiceKnowledgeLaboratoriesMalignant NeoplasmsMasksMediatingMessenger RNAMolecularMolecular BiologyMuramidaseMusMyelogenousPathway interactionsPeritonitisPhagocytesPhenotypePlayPopulationProcessProductionProteinsReporterReporter GenesResearchResearch PersonnelRoleSiteSorting - Cell MovementSpecificitySystemThioglycolatesTimeTissuesTomatoesTranscriptTransgenic MiceTransgenic OrganismsValidationWorkbasecell typecytokinegene functiongranulocyteimprovedin vivomacrophagemagnetic beadsnovelperipheral bloodpreventpromoterrecombinaseresponsetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Macrophages are crucial for tissue homeostasis and play essential roles in inflammation, immunity and cancer, and therefore understanding macrophage biology is fundamental for understanding homeostasis and disease. Currently available mice that target Cre expression for the deletion of floxed genes to macrophages have significant and severe restrictions, primarily based on the promoter driving Cre expression. 1) all of the available promoters currently driving Cre in macrophages are active in the entire myeloid lineage and even other cell types, which is frequently stronger than the one in macrophages, and therefore lack macrophage specificity; 2) currently available promoters only target a subset of macrophages; and 3) the two most commonly used Cre lines driven by F4/80 and LysM, are also knocked in one endogenous allele resulting in weak expression and prevent breeding of homozygous mice. The goal of this study is to develop and characterize a novel and improved transgenic mouse line to specifically target expression of Cre to macrophages. We propose to use the human CD68 promoter in combination with a macrophage-specific enhancer to drive expression of an activity-improved Cre and the dtTomato fluorescent protein from a bicistronic transcript for in vivo tracking and sorting. Transgenic mice will be extensively characterized with reporter genes and endogenous floxed genes and compared to the currently available Cre-expressing mice. Therefore our proposal to develop a novel true macrophage selective and specific Cre expressing mouse line in the C57BL/6 strain, and to make this mouse widely available to the research community, will significantly impact our current ability to study macrophages and will have significant ramifications for researchers studying macrophages in homeostasis, immunity and cancer, and will therefore enable the field to progress forward.
PUBLIC HEALTH RELEVANCE: Macrophages are essential for tissue homeostasis and contribute to disease. Therefore understanding macrophage biology is fundamental to advance current knowledge of these processes, which requires macrophage specific deletion of genes using the Cre recombinase. Because currently available mice expressing Cre in macrophages have severe disadvantages, our study will develop and characterize a new and substantially improved transgenic mouse with macrophage specific expression of an improved version of Cre, which will be shared with the scientific community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Macrophage Heterogeneity in Rheumatoid Arthritis
-
批准号:10392246
-
项目类别:
-
资助金额:$69.46万
-
财政年份:2022
-
负责人:Harris R Perlman
-
依托单位:
Macrophage Heterogeneity in Rheumatoid Arthritis
-
批准号:10609468
-
项目类别:
-
资助金额:$69.47万
-
财政年份:2022
-
负责人:Harris R Perlman
-
依托单位:
Synovial Macrophage Transcriptional Signatures for Predicting Therapeutic Efficacy
-
批准号:10679089
-
项目类别:
-
资助金额:$57.91万
-
财政年份:2019
-
负责人:Harris R Perlman
-
依托单位:
Synovial Macrophage Transcriptional Signatures for Predicting Therapeutic Efficacy
-
批准号:10460247
-
项目类别:
-
资助金额:$57.09万
-
财政年份:2019
-
负责人:Harris R Perlman
-
依托单位:
Transcriptional Signature of Macrophages in SSc
-
批准号:10005890
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2019
-
负责人:Harris R Perlman
-
依托单位:
Synovial Macrophage Transcriptional Signatures for Predicting Therapeutic Efficacy
-
批准号:9766023
-
项目类别:
-
资助金额:$63.65万
-
财政年份:2019
-
负责人:Harris R Perlman
-
依托单位:
Synovial Macrophage Transcriptional Signatures for Predicting Therapeutic Efficacy
-
批准号:10020786
-
项目类别:
-
资助金额:$60.02万
-
财政年份:2019
-
负责人:Harris R Perlman
-
依托单位:
Synovial Macrophage Transcriptional Signatures for Predicting Therapeutic Efficacy
-
批准号:10242125
-
项目类别:
-
资助金额:$57.49万
-
财政年份:2019
-
负责人:Harris R Perlman
-
依托单位:
Macrophage Modulation of Lung Fibrosis
-
批准号:9264201
-
项目类别:
-
资助金额:$66.72万
-
财政年份:2017
-
负责人:Harris R Perlman
-
依托单位:
RhEumatoid Arthritis SynOvial tissue Network (REASON)
-
批准号:9130014
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2014
-
负责人:Harris R Perlman
-
依托单位:
RhEumatoid Arthritis SynOvial tissue Network (REASON)
-
批准号:9130011
-
项目类别:
-
资助金额:$14.68万
-
财政年份:2014
-
负责人:Harris R Perlman
-
依托单位:
RhEumatoid Arthritis SynOvial tissue Network (REASON)
-
批准号:8851790
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2014
-
负责人:Harris R Perlman
-
依托单位:
Development of a Novel RA/Atherosclerosis Mouse Model
-
批准号:9124741
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2013
-
负责人:Harris R Perlman
-
依托单位:
Development of a Novel RA/Atherosclerosis Mouse Model
-
批准号:8618733
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2013
-
负责人:Harris R Perlman
-
依托单位:
Development of a Novel RA/Atherosclerosis Mouse Model
-
批准号:8897866
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2013
-
负责人:Harris R Perlman
-
依托单位:
Development of a Novel RA/Atherosclerosis Mouse Model
-
批准号:8735615
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2013
-
负责人:Harris R Perlman
-
依托单位:
Development of a Novel RA/Atherosclerosis Mouse Model
-
批准号:9330671
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2013
-
负责人:Harris R Perlman
-
依托单位:
A novel and improved mouse system for studying macrophage specific gene deletion
-
批准号:8204742
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2010
-
负责人:Harris R Perlman
-
依托单位:
Role of BH3-Domain Proteins in the Effector Phase of RA
-
批准号:8080888
-
项目类别:
-
资助金额:$31.89万
-
财政年份:2008
-
负责人:Harris R Perlman
-
依托单位:
Role of BH3-Domain Proteins in the Effector Phase of RA
-
批准号:7773747
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2008
-
负责人:Harris R Perlman
-
依托单位:
海外基金